Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer

ConclusionPreoperative SII seems to identify NMIBC patients who have a worse disease and prognosis. Such easily available and cheap standard biomarkers may help refine the decision-making process regarding adjuvant treatment in patients with intermediate-risk NMIBC.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research